Limited time offer! 10% off your first blood test order!
30-marker comprehensive annual review for post-menopausal women covering hormones, cardiovascular, bone, thyroid, nutrition, and organ function.
or 4 interest-free payments of £49.75 with Klarna
A comprehensive 30-marker annual wellness review for post-menopausal women — covering sex hormones, full blood count, organ function, cardiovascular risk.
The years after menopause bring significant shifts in health risk. Cardiovascular disease risk rises. Bone loss accelerates. Thyroid dysfunction becomes more common. Nutritional deficiencies — vitamin D, B12, iron — emerge or worsen. The Post-Menopause Annual Wellness Review is designed to address all of these in a single comprehensive annual assessment.
With 30 markers, this is the most thorough post-menopause wellness panel Trupoint Health offers. It covers:
Sex hormones: FSH, LH, oestradiol, testosterone, SHBG
Full blood count: haemoglobin, RBC, WBC, platelets, MCV
Organ function: six liver markers and four kidney markers
Cardiovascular: full lipid profile plus ApoB and hsCRP
Thyroid: TSH, FT4, FT3
Bone and calcium metabolism: vitamin D, corrected calcium, PTH
Nutritional: active B12, folate, ferritin
Glycaemic: HbA1c
This panel gives a comprehensive picture of health across every major system affected by post-menopausal physiology. Venous draw required; morning fasted collection essential. GMC-physician reviewed results within 5 to 7 working days.
Understand what each marker measures, why it matters, and what the science says — not just a list of numbers.
Post-menopausal hormone status including bioavailable testosterone for libido and energy assessment.
Haematological screen for anaemia, immune status, and clotting in post-menopausal women.
Liver health markers relevant for HRT safety monitoring and general organ function.
Renal function markers increasingly important as cardiovascular risk rises after menopause.
Standard lipid panel for annual cardiovascular risk monitoring.
Atherogenic particle count — the most sensitive lipid marker for post-menopausal cardiovascular risk.
Vascular inflammation marker; post-menopausal inflammatory burden predicts cardiovascular events.
Full thyroid axis — hypothyroidism is extremely common after menopause and mimics menopausal symptoms.
Bone metabolism triad — essential for monitoring post-menopausal osteoporosis risk.
Key nutritional and glycaemic markers; B12 absorption declines with age, and diabetes risk rises after menopause.
This panel is designed for adults who want a comprehensive, evidence-based picture of their metabolic health — not a GP referral panel.
Post-menopausal women wanting a thorough annual health assessment
Those on HRT wanting a comprehensive baseline and monitoring panel
Women with multiple menopausal risk areas wanting a single all-in-one assessment
Those looking to transition from ad hoc testing to a structured annual review
This panel provides a comprehensive multi-system assessment but does not include Lp(a), homocysteine, thyroid antibodies, adrenal markers, or advanced bone resorption markers (CTX, P1NP). Women on HRT should note that oestradiol, FSH, and LH values will be affected by systemic oestrogen and cannot be used as menopausal status indicators; the physician report will interpret in this context. ApoB is not included in this panel; if advanced lipid risk assessment is a priority, the Menopause Bone and Heart Health Panel or Men's Metabolic Panel should be considered. Fasting is essential — non-fasted lipids, insulin, and glucose values will not be interpretable.
From order to physician-reviewed report in as little as three working days.
Three options designed to fit your schedule, location, and preference — all producing a laboratory-standard sample.
Adults 18+ in mainland UK. Not suitable if you have had a transfusion in the last 3 months.
Order anytime; kit dispatched within 24 hours Mon–Fri.
Allow 24–48 hours for sample transit on top of lab processing time.
Adults 18+ within 20 miles of a serviced city centre.
Mon–Sun, 06:00–20:00. Next-day booking typical.
Sample reaches the lab within 24 hours of collection.
Adults 16+ with photo ID. Paediatric draws by appointment at selected sites.
Mon–Fri, with Saturday hours at most metropolitan locations.
Samples processed same-day at the receiving clinic.
Every test is processed in a UKAS ISO 15189-accredited laboratory, overseen by GMC-registered physicians, and governed by UK GDPR. No overseas processing, no offshore data.
Follow these guidelines to ensure accurate, reproducible results. Most markers are sensitive to recent food, exercise, and sleep.
Can't find your answer? Our clinical support team is available Monday to Friday, 9am–5pm.
Contact supportNHS annual health checks for women over 40 typically include blood pressure, cholesterol, and blood glucose, and are primarily focused on cardiovascular risk and diabetes. This panel goes substantially further: it includes a full hormone assessment, advanced thyroid testing (FT3 and FT4 not just TSH), bone metabolism markers (vitamin D, calcium, PTH), full blood count, liver and kidney function, active B12 (more sensitive than NHS standard B12), and high-sensitivity CRP. The result is a far more complete picture of the specific risks that increase after menopause, reviewed and interpreted by a GMC-registered physician.
Yes, and it is particularly useful as an annual HRT monitoring assessment. The sex hormone results will reflect the combined effect of endogenous production and HRT, which the physician will interpret in context. Lipids are monitored because some HRT formulations affect triglycerides and cholesterol. Liver function is relevant for HRT safety monitoring (particularly for oral oestrogen users). Bone markers and vitamin D confirm whether HRT’s bone-protective effects are being supported by adequate nutritional status. Please note all HRT details clearly in your profile so the physician can give a fully contextualised interpretation.
The risk of type 2 diabetes increases after menopause due to several converging factors: oestrogen decline reduces insulin sensitivity, body fat distribution shifts towards visceral fat (a metabolic risk factor), physical activity often reduces, and some medications used in post-menopausal women (including corticosteroids) worsen glycaemic control. Including HbA1c in the annual review allows early identification of pre-diabetes before it progresses to overt diabetes. Regular monitoring also provides a meaningful trend — gradually rising HbA1c over several years signals a metabolic trajectory that warrants intervention.
Your Trupoint Health physician report is structured to prioritise findings by clinical significance rather than simply flagging every out-of-range value. The most urgent findings — such as significantly elevated PTH with raised calcium, very low oestradiol on established HRT, or a markedly abnormal blood count — will be highlighted for prompt action. Moderate findings will be contextualised and placed within a recommended management timeline. Low-priority findings that warrant monitoring but not immediate action will be noted for your awareness. The report is designed to be practical and actionable, not overwhelming.
Annual testing is recommended for most post-menopausal women as a structured health review. The breadth of the panel allows most key health risks to be captured in a single annual assessment rather than ad hoc testing across the year. If you are on HRT, annual testing allows monitoring of safety markers and response to treatment. If specific deficiencies are identified and addressed, retesting the relevant markers (rather than the full panel) at 3 to 4 months confirms treatment response. The physician report will recommend specific retesting intervals for any significantly abnormal values.
